Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NAAA | Q02083 | 1/20 | 0.64 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.59 |
| ▸ | HCAR2 | Q8TDS4 | 2/20 | 0.59 |
| ▸ | TSHR | P16473 | 3/20 | 0.57 |
| ▸ | RAD52 | P43351 | 1/20 | 0.53 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.52 |
| ▸ | DGKA | P23743 | 1/20 | 0.52 |
| ▸ | ACHE | P22303 | 6/20 | 0.52 |
| ▸ | FAAH | O00519 | 1/20 | 0.52 |
| ▸ | LMNA | P02545 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1014736 | 1.00 | NAAA (0.64) | NAAAEPHX1HCAR2TSHRRAD52 | |
| SCHEMBL1835020 | 1.00 | NAAA (0.64) | NAAAEPHX1HCAR2TSHRRAD52 | |
| SCHEMBL1835071 | 1.00 | NAAA (0.64) | NAAAEPHX1HCAR2TSHRRAD52 | |
| SCHEMBL1833011 | 1.00 | NAAA (0.64) | NAAAEPHX1HCAR2TSHRRAD52 | |
| SCHEMBL1832879 | 1.00 | NAAA (0.64) | NAAAEPHX1HCAR2TSHRRAD52 | |
| SCHEMBL1836119 | 1.00 | NAAA (0.64) | NAAAEPHX1HCAR2TSHRRAD52 | |
| SCHEMBL1254240 | 1.00 | NAAA (0.64) | NAAAEPHX1HCAR2TSHRRAD52 | |
| SCHEMBL1255545 | 1.00 | NAAA (0.64) | NAAAEPHX1HCAR2TSHRRAD52 | |
| SCHEMBL1837716 | 1.00 | NAAA (0.64) | NAAAEPHX1HCAR2TSHRRAD52 | |
| SCHEMBL1835360 | 1.00 | NAAA (0.64) | NAAAEPHX1HCAR2TSHRRAD52 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 760 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024245992-A1 | IMPLANT FOR EYE | UNIVERSITEIT MAASTRICHT (NL) | 2024-12-05 | — | — | WO | claimed |
| CN-118271820-A | Polycarbonate diol modified polycarbonate matrix composite material and preparation method thereof | 厦门天宇新材料科技有限公司 | 2024-07-02 | — | — | CN | claimed |
| CN-118108921-A | Biocompatible and biostable polydimethylsiloxane polyurethane urea with chain extension of urea-based chain extender, preparation and application | 北京理工大学 | 2024-05-31 | — | — | CN | claimed |
| CN-116855214-A | Polyurethane hot melt adhesive for outdoor sport functional fabric and preparation method thereof | 东莞聚力创新材料科技有限公司 | 2023-10-10 | — | — | CN | claimed |
| CN-115584235-B | PUR adhesive for clothing fabric and preparation method thereof | 东莞聚力创新材料科技有限公司 | 2023-08-08 | — | — | CN | claimed |
| CN-113478795-B | Preparation method of phase difference compensation optical film | 沈勇 | 2023-05-23 | — | — | CN | claimed |
| CN-115651157-A | Preparation method of high-performance integrated polyurethane elastomer auxetic material | 北京化工大学 | 2023-01-31 | — | — | CN | claimed |
| CN-115584120-A | Preparation method of polyurethane elastomer composite material with negative Poisson ratio property | 北京化工大学 | 2023-01-10 | — | — | CN | claimed |
| CN-113478795-A | Method for preparing phase difference compensation optical film | 沈勇 | 2021-10-08 | — | — | CN | claimed |
| WO-2021058159-A1 | PRODUCT FOR DYEING KERATINOUS MATERIAL, CONTAINING AMINOSILICONE, A CHROMOPHORIC COMPOUND AND AN ORGANIC CARBONIC ACID ESTER | HENKEL AG & CO. KGAA (DE) | 2021-04-01 | — | — | WO | claimed |
| US-7625943-B2 | 5-alkyl-7-alkylcarbonate-isoflavone ester and related method | ROBERTS WILLIAM J | 2009-12-01 | — | — | US | claimed |
| CN-1997675-A | Olefin polymerization process in the presence of a radical generating system | INNOVENE INC (US) | 2007-07-11 | — | — | CN | claimed |
| US-20070092801-A1 | Molten Salt Electrolyte for a Battery and Electrochemical Capacitor | NANO-ELECTROCHEM, INC. | 2007-04-26 | — | — | US | claimed |
| US-20050113354-A1 | Bioavailable prodrugs of androgenic steroids and related method | ROBERTS WILLIAM J (US) | 2005-05-26 | — | — | US | claimed |
| US-20050065354-A1 | 5-alkyl-7-alkylcarbonate-isoflavone ester and related method | ROBERTS WILLIAM J (US) | 2005-03-24 | — | — | US | claimed |
| US-6818668-B2 | ADMINISTERING PRODRUGS OF METABOLITES SUCH AS 5-METHYL-7-ETHYL CARBONATE-ISOFLAVONE, TO INCREASING CONCENTRATION OF FLAVONOIDS | BIOTEST LABORATORIES, LLC | 2004-11-16 | — | — | US | claimed |
| US-6740646-B2 | Bioavailable prodrugs of androgenic steroids and related method | BIOTEST LABORATORIES, LLC | 2004-05-25 | — | — | US | claimed |
| WO-2003087083-A1 | 5-ALKYL-7-ALKYLCARBONATE-ISOFLAVONE ESTER AS ISOFLAVONE PRODRUG | BIOTEST LABORATORIES, LLC (US) | 2003-10-23 | — | — | WO | claimed |
| US-20030195245-A1 | 5-alkyl-7-alkylcarbonate-isoflavone ester and related method | BIOTEST LABORATORIES, LLC | 2003-10-16 | — | — | US | claimed |
| US-20030134830-A1 | Bioavailable prodrugs of androgenic steroids and related method | BIOTEST LABORATORIES, LLC | 2003-07-17 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030195245-A1 | 5-alkyl-7-alkylcarbonate-isoflavone ester and related method | CYP2A7, CYP8B1, CYP3A7 | NAAA 517/4885EPHX1 1230/4885HCAR2 198/4885 |
| US-20050065354-A1 | 5-alkyl-7-alkylcarbonate-isoflavone ester and related method | CYP2A7, CYP8B1, CYP3A7 | NAAA 519/4885EPHX1 1245/4885HCAR2 194/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.